<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05017519</url>
  </required_header>
  <id_info>
    <org_study_id>MSD MISP 60284</org_study_id>
    <nct_id>NCT05017519</nct_id>
  </id_info>
  <brief_title>Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus</brief_title>
  <official_title>Epidemiology and Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus in Children and Elderly: a Household-based Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mackay Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This household-based prospective cohort study aims to stablish the household transmission of&#xD;
      Respiratory syncytial virus and S. pneumoniae especially in the elderly and infants/children&#xD;
      as well as inter-relationship between S. pneumoniae and Respiratory syncytial virus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A household-based prospective cohort study will be conducted from 2021 to 2025 in northern&#xD;
      Taiwan. We will invite 240 households, having a baby who is discharged from MacKay children's&#xD;
      Hospital. The households will be classified into nuclear family type and extended family&#xD;
      type. The &quot;Nuclear family type&quot; is defined as husband and wife with baby (aged less than 5&#xD;
      months) and with or without children (2-5) and the &quot;Extended family type&quot; (three-generation&#xD;
      family) is defined as husband and wife with baby (aged less than 5 months), children (2-5),&#xD;
      and grandparents aged &gt; 65 years old. We will initially complete an enrollment form to&#xD;
      collect baseline data, including patient demographics, prior medical history, season when&#xD;
      discharge, neonatal course and households. A LINE-based management will be done weekly by&#xD;
      study team to see if there are any respiratory symptoms in household. In addition to the&#xD;
      monthly physician weekly LINE response, the research nurse will contact the parents or legal&#xD;
      guardians by telephone monthly for the 24 months to obtain data on changes in baseline&#xD;
      information, and specific facts regarding possible respiratory infections after the last&#xD;
      contact. If the households present with respiratory symptoms, the visit will be arranged as&#xD;
      early as possible. When they presenting to the emergency department, outpatient clinic, or&#xD;
      inpatient ward, the urine will be collected for the serotype-specific urinary antigen&#xD;
      detection (SSUAD) assays and the nasopharyngeal or throat swab for polymerase chain reaction&#xD;
      will be performed to study serotype of S. pneumoniae and Respiratory syncytial virus&#xD;
      subgroup. If the subjects who have clinical syndromes suggestive of pneumonia or&#xD;
      bronchopneumonia, they will be asked to participate in the further study along with their&#xD;
      household family members. Nasopharyngeal aspiration, urine, blood, and induced sputum will be&#xD;
      collected for cultures, polymerase chain reaction and serological test. Clinical&#xD;
      manifestations, disease course, and outcomes will be recorded. Family members in the same&#xD;
      household will asked to undergo screening with a nasopharyngeal or throat swab and urine&#xD;
      sample. We will trace back 2-week contact history of children in nuclear family who get&#xD;
      Respiratory syncytial virus or pneumococcal infections, especially focus on other family&#xD;
      members. The data will be further analyzed to evaluate the influence of short period and long&#xD;
      period contact.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Household transmission of Streptococcus pneumoniae and Respiratory syncytial virus</measure>
    <time_frame>2 years</time_frame>
    <description>The primary endpoint is the Streptococcus pneumoniae and Respiratory syncytial virus isolation rates in children and their household contacts of different family type.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The serotype of Streptococcus pneumoniae and Respiratory syncytial virus in post-Prevenar 13 era</measure>
    <time_frame>2 years</time_frame>
    <description>The secondary endpoint is the serotype of Streptococcus pneumoniae and Respiratory syncytial virus in post-Prevenar 13 era.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Streptococcus Pneumoniae Infection</condition>
  <condition>Respiratory Syncytial Virus Infections</condition>
  <arm_group>
    <arm_group_label>Nuclear family type</arm_group_label>
    <description>The husband and wife with baby (aged less than 5 months) and with or without children (2-5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extended family type (three-generation family)</arm_group_label>
    <description>The husband and wife with baby (aged less than 5 months), children (2-5), and grandparents aged &gt; 65 years old</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Nasopharyngeal or throat swab and urine sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        A household-based prospective cohort study will invite 240 households, having a baby who is&#xD;
        discharged from MacKay children's Hospital. The households will be classified into nuclear&#xD;
        family type and extended family type. The &quot;Nuclear family type&quot; is defined as husband and&#xD;
        wife with baby (aged less than 5 months) and with or without children (2-5) and the&#xD;
        &quot;Extended family type&quot; (three-generation family) is defined as husband and wife with baby&#xD;
        (aged less than 5 months), children (2-5), and grandparents aged &gt; 65 years old.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indicator case: Babies under 5 months of age were born in Mackay Children's Hospital&#xD;
             and had no acute respiratory infection-like symptoms that required medical&#xD;
             intervention when they agreed to participate in the trial.&#xD;
&#xD;
          -  Family members: family members living with the Indicator case, including 2-5 years old&#xD;
             siblings, parents and grandparents over 65 years old.&#xD;
&#xD;
          -  Willing to sign the informed consent form and agree to join the official LINE account&#xD;
             to receive research tracking.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Babies older than 5 months&#xD;
&#xD;
          -  Co-morbid medical conditions of the baby such as chronic lung disease, cyanotic&#xD;
             congenital heart disease, neuromuscular disease and a primary immunodeficiency.&#xD;
&#xD;
          -  Family members who do not live with the Indicator case&#xD;
&#xD;
          -  Family with grandparents younger than 65 years old&#xD;
&#xD;
          -  Someone living with family members refuses to participate in the research.&#xD;
&#xD;
          -  Unwilling to sign informed consent form or refuse to join the official LINE account to&#xD;
             receive tracking.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hsin Chi, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mackay Children's Hospital in Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hsin Chi, Doctor</last_name>
    <phone>+886 975835388</phone>
    <email>chi4531@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nan-Chang Chiu, Doctor</last_name>
    <phone>+886 975835382</phone>
    <email>ncc88@mmh.org.tw</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Huang YC, Lin CF, Ting PJ, Tang TH, Huang FL, Chao HJ, Wang CL, Chen PY. Respiratory pathogens - Some altered antibiotic susceptibility after implementation of pneumococcus vaccine and antibiotic control strategies. J Microbiol Immunol Infect. 2020 Oct;53(5):682-689. doi: 10.1016/j.jmii.2019.08.015. Epub 2019 Oct 18.</citation>
    <PMID>31859164</PMID>
  </results_reference>
  <results_reference>
    <citation>Lu CY, Chiang CS, Chiu CH, Wang ET, Chen YY, Yao SM, Chang LY, Huang LM, Lin TY, Chou JH. Successful Control of Streptococcus pneumoniae 19A Replacement With a Catch-up Primary Vaccination Program in Taiwan. Clin Infect Dis. 2019 Oct 15;69(9):1581-1587. doi: 10.1093/cid/ciy1127.</citation>
    <PMID>30923808</PMID>
  </results_reference>
  <results_reference>
    <citation>Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10(9):e1001517. doi: 10.1371/journal.pmed.1001517. Epub 2013 Sep 24.</citation>
    <PMID>24086113</PMID>
  </results_reference>
  <results_reference>
    <citation>Chi HC, Hsieh YC, Tsai MH, Lee CH, Kuo KC, Huang CT, Huang YC. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan. J Microbiol Immunol Infect. 2018 Jun;51(3):332-336. doi: 10.1016/j.jmii.2016.08.009. Epub 2016 Dec 18.</citation>
    <PMID>28082066</PMID>
  </results_reference>
  <results_reference>
    <citation>Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, Andrews NJ, Miller E, Ramsay ME. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. Lancet Infect Dis. 2018 Apr;18(4):441-451. doi: 10.1016/S1473-3099(18)30052-5. Epub 2018 Jan 26. Erratum in: Lancet Infect Dis. 2018 Feb 6;:.</citation>
    <PMID>29395999</PMID>
  </results_reference>
  <results_reference>
    <citation>Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877.</citation>
    <PMID>19196675</PMID>
  </results_reference>
  <results_reference>
    <citation>Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, Mejías A, Baraldi E, Papadopoulos NG, Nair H, Nunes MC, Kragten-Tabatabaie L, Heikkinen T, Greenough A, Stein RT, Manzoni P, Bont L, Martinón-Torres F. Respiratory Syncytial Virus Seasonality: A Global Overview. J Infect Dis. 2018 Apr 11;217(9):1356-1364. doi: 10.1093/infdis/jiy056. Review.</citation>
    <PMID>29390105</PMID>
  </results_reference>
  <results_reference>
    <citation>Lin CY, Hwang D, Chiu NC, Weng LC, Liu HF, Mu JJ, Liu CP, Chi H. Increased Detection of Viruses in Children with Respiratory Tract Infection Using PCR. Int J Environ Res Public Health. 2020 Jan 15;17(2). pii: E564. doi: 10.3390/ijerph17020564.</citation>
    <PMID>31952364</PMID>
  </results_reference>
  <results_reference>
    <citation>Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019 Aug 31;394(10200):757-779. doi: 10.1016/S0140-6736(19)30721-4. Epub 2019 Jun 27. Erratum in: Lancet. 2019 Aug 31;394(10200):736.</citation>
    <PMID>31257127</PMID>
  </results_reference>
  <results_reference>
    <citation>Wolf DG, Greenberg D, Shemer-Avni Y, Givon-Lavi N, Bar-Ziv J, Dagan R. Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr. 2010 Jan;156(1):115-20. doi: 10.1016/j.jpeds.2009.07.014.</citation>
    <PMID>19782998</PMID>
  </results_reference>
  <results_reference>
    <citation>Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015 Feb 26;372(9):835-45. doi: 10.1056/NEJMoa1405870.</citation>
    <PMID>25714161</PMID>
  </results_reference>
  <results_reference>
    <citation>Chiu NC, Lin HY, Hsu CH, Huang FY, Lee KS, Chi H. Epidemiological and microbiological characteristics of culture-proven acute otitis media in Taiwanese children. J Formos Med Assoc. 2012 Oct;111(10):536-41. doi: 10.1016/j.jfma.2011.07.015. Epub 2012 Mar 13.</citation>
    <PMID>23089688</PMID>
  </results_reference>
  <results_reference>
    <citation>Kung YH, Chiu NC, Lee KS, Chang L, Huang DT, Huang FY, Hsieh YC, Huang LM, Chi H. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children. J Microbiol Immunol Infect. 2014 Jun;47(3):239-44. doi: 10.1016/j.jmii.2013.08.016. Epub 2013 Sep 27.</citation>
    <PMID>24080520</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel JA, Nguyen DT, Revai K, Chonmaitree T. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine. 2007 Feb 19;25(9):1683-9. Epub 2006 Nov 9.</citation>
    <PMID>17156899</PMID>
  </results_reference>
  <results_reference>
    <citation>de Steenhuijsen Piters WA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC, Chaussabel D, Cohen DM, Sanders EA, Ramilo O, Bogaert D, Mejias A. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. Am J Respir Crit Care Med. 2016 Nov 1;194(9):1104-1115.</citation>
    <PMID>27135599</PMID>
  </results_reference>
  <results_reference>
    <citation>Tsolia MN, Psarras S, Bossios A, Audi H, Paldanius M, Gourgiotis D, Kallergi K, Kafetzis DA, Constantopoulos A, Papadopoulos NG. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004 Sep 1;39(5):681-6. Epub 2004 Aug 13.</citation>
    <PMID>15356783</PMID>
  </results_reference>
  <results_reference>
    <citation>Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, Byington CL. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008 Aug;122(2):229-37. doi: 10.1542/peds.2007-3192.</citation>
    <PMID>18676537</PMID>
  </results_reference>
  <results_reference>
    <citation>Brealey JC, Chappell KJ, Galbraith S, Fantino E, Gaydon J, Tozer S, Young PR, Holt PG, Sly PD. Streptococcus pneumoniae colonization of the nasopharynx is associated with increased severity during respiratory syncytial virus infection in young children. Respirology. 2018 Feb;23(2):220-227. doi: 10.1111/resp.13179. Epub 2017 Sep 15.</citation>
    <PMID>28913912</PMID>
  </results_reference>
  <results_reference>
    <citation>Nguyen DT, Louwen R, Elberse K, van Amerongen G, Yüksel S, Luijendijk A, Osterhaus AD, Duprex WP, de Swart RL. Streptococcus pneumoniae Enhances Human Respiratory Syncytial Virus Infection In Vitro and In Vivo. PLoS One. 2015 May 13;10(5):e0127098. doi: 10.1371/journal.pone.0127098. eCollection 2015.</citation>
    <PMID>25970287</PMID>
  </results_reference>
  <results_reference>
    <citation>Greenberg D, Givon-Lavi N, Faingelernt Y, Ben-Shimol S, Avni YS, Bar-Ziv J, Dagan R. Nasopharyngeal Pneumococcal Carriage During Childhood Community-Acquired Alveolar Pneumonia: Relationship Between Specific Serotypes and Coinfecting Viruses. J Infect Dis. 2017 Apr 1;215(7):1111-1116. doi: 10.1093/infdis/jiw613.</citation>
    <PMID>28011920</PMID>
  </results_reference>
  <results_reference>
    <citation>Althouse BM, Hammitt LL, Grant L, Wagner BG, Reid R, Larzelere-Hinton F, Weatherholtz R, Klugman KP, Rodgers GL, O'Brien KL, Hu H. Identifying transmission routes of Streptococcus pneumoniae and sources of acquisitions in high transmission communities. Epidemiol Infect. 2017 Oct;145(13):2750-2758. doi: 10.1017/S095026881700125X. Epub 2017 Aug 29.</citation>
    <PMID>28847317</PMID>
  </results_reference>
  <results_reference>
    <citation>Tramuto F, Amodio E, Calamusa G, Restivo V, Costantino C, Vitale F; The BINOCOLO Group. Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in Sicily. Int J Mol Sci. 2017 Jan 6;18(1). pii: E105. doi: 10.3390/ijms18010105.</citation>
    <PMID>28067813</PMID>
  </results_reference>
  <results_reference>
    <citation>Walsh EE, Falsey AR. Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets. 2012 Apr;12(2):98-102. Review.</citation>
    <PMID>22335500</PMID>
  </results_reference>
  <results_reference>
    <citation>Agoti CN, Munywoki PK, Phan MVT, Otieno JR, Kamau E, Bett A, Kombe I, Githinji G, Medley GF, Cane PA, Kellam P, Cotten M, Nokes DJ. Transmission patterns and evolution of respiratory syncytial virus in a community outbreak identified by genomic analysis. Virus Evol. 2017 Mar 11;3(1):vex006. doi: 10.1093/ve/vex006. eCollection 2017 Jan.</citation>
    <PMID>28458916</PMID>
  </results_reference>
  <results_reference>
    <citation>Crowcroft NS, Zambon M, Harrison TG, Mok Q, Heath P, Miller E. Respiratory syncytial virus infection in infants admitted to paediatric intensive care units in London, and in their families. Eur J Pediatr. 2008 Apr;167(4):395-9. Epub 2007 May 31.</citation>
    <PMID>17541638</PMID>
  </results_reference>
  <results_reference>
    <citation>Otomaru H, Kamigaki T, Tamaki R, Okamoto M, Alday PP, Tan AG, Manalo JI, Segubre-Mercado E, Inobaya MT, Tallo V, Lupisan S, Oshitani H. Transmission of Respiratory Syncytial Virus Among Children Under 5 Years in Households of Rural Communities, the Philippines. Open Forum Infect Dis. 2019 Mar 11;6(3):ofz045. doi: 10.1093/ofid/ofz045. eCollection 2019 Mar. Erratum in: Open Forum Infect Dis. 2019 Jul 13;6(7):ofz213.</citation>
    <PMID>30882012</PMID>
  </results_reference>
  <results_reference>
    <citation>Munywoki PK, Koech DC, Agoti CN, Lewa C, Cane PA, Medley GF, Nokes DJ. The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya. J Infect Dis. 2014 Jun 1;209(11):1685-92. doi: 10.1093/infdis/jit828. Epub 2013 Dec 23.</citation>
    <PMID>24367040</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim L, Rha B, Abramson JS, Anderson LJ, Byington CL, Chen GL, DeVincenzo J, Edwards KM, Englund JA, Falsey AR, Griffin MR, Karron RA, Martin KG, Meissner HC, Munoz FM, Pavia AT, Piedra PA, Schaffner W, Simões EAF, Singleton R, Talbot HK, Walsh EE, Zucker JR, Gerber SI. Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines. Clin Infect Dis. 2017 Sep 15;65(6):1020-1025. doi: 10.1093/cid/cix432.</citation>
    <PMID>28903503</PMID>
  </results_reference>
  <results_reference>
    <citation>Midgley CM, Haynes AK, Baumgardner JL, Chommanard C, Demas SW, Prill MM, Abedi GR, Curns AT, Watson JT, Gerber SI. Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing. J Infect Dis. 2017 Aug 1;216(3):345-355. doi: 10.1093/infdis/jix275.</citation>
    <PMID>28859428</PMID>
  </results_reference>
  <results_reference>
    <citation>Smith CM, Sandrini S, Datta S, Freestone P, Shafeeq S, Radhakrishnan P, Williams G, Glenn SM, Kuipers OP, Hirst RA, Easton AJ, Andrew PW, O'Callaghan C. Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. Am J Respir Crit Care Med. 2014 Jul 15;190(2):196-207. doi: 10.1164/rccm.201311-2110OC.</citation>
    <PMID>24941423</PMID>
  </results_reference>
  <results_reference>
    <citation>Yan T, Tang X, Sun L, Tian R, Li Z, Liu G. Co infection of respiratory syncytial viruses (RSV) and streptococcus pneumonia modulates pathogenesis and dependent of serotype and phase variant. Microb Pathog. 2020 Jul;144:104126. doi: 10.1016/j.micpath.2020.104126. Epub 2020 Mar 12.</citation>
    <PMID>32173494</PMID>
  </results_reference>
  <results_reference>
    <citation>Chi H, Liu HF, Weng LC, Wang NY, Chiu NC, Lai MJ, Lin YC, Chiu YY, Hsieh WS, Huang LM. Molecular epidemiology and phylodynamics of the human respiratory syncytial virus fusion protein in northern Taiwan. PLoS One. 2013 May 29;8(5):e64012. doi: 10.1371/journal.pone.0064012. Print 2013.</citation>
    <PMID>23734183</PMID>
  </results_reference>
  <results_reference>
    <citation>Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006 Jan;44(1):124-31.</citation>
    <PMID>16390959</PMID>
  </results_reference>
  <results_reference>
    <citation>Leung MH, Bryson K, Freystatter K, Pichon B, Edwards G, Charalambous BM, Gillespie SH. Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy. J Clin Microbiol. 2012 Jul;50(7):2419-27. doi: 10.1128/JCM.06384-11. Epub 2012 May 2.</citation>
    <PMID>22553238</PMID>
  </results_reference>
  <results_reference>
    <citation>Melegaro A, Gay NJ, Medley GF. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect. 2004 Jun;132(3):433-41.</citation>
    <PMID>15188713</PMID>
  </results_reference>
  <results_reference>
    <citation>Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for case-control genetic association analyses. BMC Genet. 2008 May 13;9:36. doi: 10.1186/1471-2156-9-36.</citation>
    <PMID>18477402</PMID>
  </results_reference>
  <results_reference>
    <citation>Erästö P, Hoti F, Auranen K. Modeling transmission of multitype infectious agents: application to carriage of Streptococcus pneumoniae. Stat Med. 2012 Jun 30;31(14):1450-63. doi: 10.1002/sim.4487. Epub 2012 Feb 21.</citation>
    <PMID>22354452</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, Chan WK, Hsu KH, Fang TY, Huang YC, Lin TY. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004 Jan 14;291(2):222-7.</citation>
    <PMID>14722149</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang KS, Liu X, Ategbole M, Xie X, Liu Y, Xu C, Xie C, Sha Z. Generalized Linear Mixed Model Analysis of Urban-Rural Differences in Social and Behavioral Factors for Colorectal Cancer Screening. Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2581-2589.</citation>
    <PMID>28952708</PMID>
  </results_reference>
  <results_reference>
    <citation>Glorioso TJ, Grunwald GK, Ho PM, Maddox TM. Reference effect measures for quantifying, comparing and visualizing variation from random and fixed effects in non-normal multilevel models, with applications to site variation in medical procedure use and outcomes. BMC Med Res Methodol. 2018 Jul 6;18(1):74. doi: 10.1186/s12874-018-0517-7.</citation>
    <PMID>29980180</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mackay Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Hsin Chi</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Streptococcus Pneumoniae</keyword>
  <keyword>Respiratory Syncytial Virus</keyword>
  <keyword>household-based</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Pneumococcal</mesh_term>
    <mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
    <mesh_term>Pneumococcal Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We will record and analyze the individual participant data by our study team only.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 11, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT05017519/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

